Revolution Medicines (RVMD) Asset Utilization Ratio (2020 - 2024)

Revolution Medicines has reported Asset Utilization Ratio for 5 years, with the latest figure at 0.0 in Q3 2024.

• On a quarterly basis, Asset Utilization Ratio fell 98.37% year-over-year to 0.0 in Q3 2024; TTM through Sep 2024 was 0.0, a 98.37% decrease from a year earlier, with the FY2023 full-year figure at 0.01, down 82.35% from the prior year.
• Asset Utilization Ratio was 0.0 for Q3 2024 at Revolution Medicines, up from 0.0 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.14 in Q1 2020, with the low at 0.0 in Q2 2024.
• Average Asset Utilization Ratio over 5 years is 0.05, with a median of 0.04 recorded in 2021.
• The sharpest annual moves came in 2022 and 2024: Asset Utilization Ratio advanced 8.26% in 2022, then tumbled 98.55% in 2024.
• Over 5 years, Asset Utilization Ratio stood at 0.07 in 2020, then slumped by 46.04% to 0.04 in 2021, then grew by 8.26% to 0.04 in 2022, then sank by 82.4% to 0.01 in 2023, then tumbled by 94.54% to 0.0 in 2024.
• The last three Asset Utilization Ratio figures came in at 0.0 (Q3 2024), 0.0 (Q2 2024), and 0.0 (Q1 2024), per Business Quant data.